Design Therapeutics, Inc. ( DSGN) - Stock Earnings
DSGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -17.0 million USD | — USD |
| 2025Q4 | -16.0 million USD | — USD |
| 2026Q1 | -17.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DSGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -66.9 million USD | — USD |
| 2024 | -49.6 million USD | — USD |
| 2025 | -69.8 million USD | — USD |
| 2026 Est. | — | — |
DSGN
Price: $10.58
52 week price:
Earnings Per Share: -1.20 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 301800
Market Capitalization: 652.1 million